What Is PalliaTech

PalliaTech is a holding company whose national network of operating entities constitutes one of America’s largest and fastest-growing, vertically integrated cannabis companies.

PalliaTech presently has operations in eleven states,

spanning key markets on the East and West coasts, with plans in place to enter additional states. The three primary activities for its subsidiaries are the cultivating, processing and dispensing of medical cannabis for the Curaleaf brand.

PalliaTech’s Management Team

PalliaTech’s highly experienced management team has world-class expertise in operating cannabis companies. Areas of expertise include:

  • Cultivation
  • Manufacturing
  • Distribution
  • Research and development

The management team oversees the work of an unparalleled staff of scientists, doctors and business advisors. PalliaTech and its operating companies receive guidance from a distinguished Medical Advisory Board comprised of experts in the fields of cancer care, palliative care and cannabis science.

Joseph Lusardi

President and CEO

Stuart Wilcox

Chief Operating Officer

Jonathan Faucher

EVP of Finance

Carolyn Fedigan

SVP of Human Resources

Katrina Yolen

SVP of Marketing

Christine Rigby

SVP of Investor Relations

Ed Conklin

SVP of Government Relations

Robert Winnicki

SVP of Research and Product Development

Ed Kelenchuk

SVP of Business Development

Gretchen McCarthy

VP of Dispensary Operations

Matthew Harrell

VP of Government Relations

Peter Clateman

General Counsel

Jesse Kater

VP of Product Research

John Dol

VP of Cultivation

Keisha Brice

VP of Compliance

Boris Jordan

Chairman of the Board

Dr. Steven Patierno, PhD

Chairman of the Medical Advisory Board

Dr. David Casarett, MD

Member of the Medical Advisory Board

Dr. Robert Schnoll, PhD

Member of the Medical Advisory Board

Dr. Brian F. Thomas

Member of the Medical Advisory Board